Figure 5
Classification performance of the IL10 cut-off model. (a) ROC curve from cohort I (n = 32) showed an AUC of 0.736 (p = 0.022). The relevant cut-off value was 13.5 pg/mL. (b) The difference in PR in cohort I was significant (p = 0.004; no PR of 13 for ≤ 13.5 pg/mL and 9 PR of 19 for > 13.5 pg/mL in cohort I). (c) The difference in PR in cohort II (n = 29) was also significant (p = 0.031; two PRs of 15 for ≤ 13.5 pg/mL and 7 PRs of 14 for > 13.5 pg/mL in cohort II). (d) The ROC curve from cohort I without SR (n = 21) showed an AUC of 0.838 (p = 0.026). The relevant cut-off value was 18.6 pg/mL. (e) The difference in PR in cohort I without SR was significant (p = 0.021; no PR of 10 for ≤ 18.6 pg/mL and 5 PR of 11 for > 18.6 pg/mL in cohort I). (f) The difference in PR in cohort II (n = 21) without SR was also significant (p = 0.011; no PR of 13 for ≤ 18.6 pg/mL and 3 PR of 8 for > 18.6 pg/mL in cohort II). ROC receiver operating characteristic, AUC area under the curve, PR peritoneal recurrence, SR systemic recurrence).
